STI Stock Trade Intelligence
DRUG

Betashares Global Healthcare Currency Hedged ETF

Financials · ASX:DRUG
$9.95
▲ +0.81%
Market cap
$191M
Turnover
$274,218
Last price
$9.95
Day change
+0.81%
Announcements
0
Range, past year
Open 8.130 · Low 8.100 · Now 9.950 · High 10.05
Open DRUG in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.

DRUG momentum and trend analysis

Our analysis
Independent analysis generated by Stock Trade Intelligence as at 2026-11-16.
Momentum quality
59/100
Wyckoff phase
Uptrend22d
Trend stage
Emerging
1 Day
+0.8%
1 Week
+1.5%
1 Month
+7.0%
RSI
63
Avg daily range
1.3%

Betashares Global Healthcare Currency Hedged ETF scores 59 out of 100 for momentum quality, a reading rated medium confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Emerging.

On the Wyckoff cycle it sits in Uptrend, where it has been for 22 trading days. The weekly timeframe reads Uptrend, which agrees with the daily view.

Against the wider market it is currently matching and the institutional accumulation signal reads moderate.

What stands out
  • Fresh trend age (23 days)
  • Within 1.0% of 52-week high
  • RSI in healthy zone (63)
  • Near-term opportunity score 72
Points to watch
Nothing flagged for DRUG on this reading.
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highs

DRUG announcements

Recent price-sensitive releases.

No price-sensitive announcements on file for DRUG.

Get the daily briefing The day's price-sensitive announcements, ranked by what actually moved, with our own momentum and cycle read on each.